Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 240 entries
Sorted by: Best Match Show Resources per page
Effectiveness of agomelatine on anhedonia in depressed patients: An outpatient, open-label, real-world study.

Human psychopharmacology

[No authors listed]
PMID: 28657181
Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2597.

No abstract available.

Cite
Effectiveness of agomelatine on anhedonia in depressed patients: An outpatient, open-label, real-world study. Hum Psychopharmacol. 2017;32(3)doi: 10.1002/hup.2597.
(2017). Effectiveness of agomelatine on anhedonia in depressed patients: An outpatient, open-label, real-world study. Human psychopharmacology, 32(3), . https://doi.org/10.1002/hup.2597
"Effectiveness of agomelatine on anhedonia in depressed patients: An outpatient, open-label, real-world study." Human psychopharmacology vol. 32,3 (2017). doi: https://doi.org/10.1002/hup.2597
Effectiveness of agomelatine on anhedonia in depressed patients: An outpatient, open-label, real-world study. Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2597. PMID: 28657181.
Copy Download .nbib Format: NLM
Changes in plasma monoamine metabolites during acute lithium intoxication.

Human psychopharmacology

Yoshimura R, Yamada Y, Ueda N, Nakamura J.
PMID: 12404314
Hum Psychopharmacol. 2000 Jul;15(5):357-360. doi: 10.1002/1099-1077(200007)15:5<357::AID-HUP174>3.0.CO;2-K.

A case of acute lithium intoxication is presented in which plasma levels of 3-methyoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxyindoleacetic acid (5-HIAA), and homovanillic acid (HVA) were longitudinally measured during the intoxication period. Plasma levels of MHPH and 5-HIAA, but not HVA were...

Cite
Yoshimura R, Yamada Y, Ueda N, et al. Changes in plasma monoamine metabolites during acute lithium intoxication. Hum Psychopharmacol. 2000;15(5):357-360doi: 10.1002/1099-1077(200007)15:5<357::AID-HUP174>3.0.CO;2-K.
Yoshimura, R., Yamada, Y., Ueda, N., & Nakamura, J. (2000). Changes in plasma monoamine metabolites during acute lithium intoxication. Human psychopharmacology, 15(5), 357-360. https://doi.org/10.1002/1099-1077(200007)15:5<357::AID-HUP174>3.0.CO;2-K
Yoshimura, Reiji, et al. "Changes in plasma monoamine metabolites during acute lithium intoxication." Human psychopharmacology vol. 15,5 (2000): 357-360. doi: https://doi.org/10.1002/1099-1077(200007)15:5<357::AID-HUP174>3.0.CO;2-K
Yoshimura R, Yamada Y, Ueda N, Nakamura J. Changes in plasma monoamine metabolites during acute lithium intoxication. Hum Psychopharmacol. 2000 Jul;15(5):357-360. doi: 10.1002/1099-1077(200007)15:5<357::AID-HUP174>3.0.CO;2-K. PMID: 12404314.
Copy Download .nbib Format: NLM
Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders.

Human psychopharmacology

McEwen BS, Magarinos AM.
PMID: 12404531
Hum Psychopharmacol. 2001 Jan;16:S7-S19. doi: 10.1002/hup.266.

The hippocampal formation, a structure involved in declarative, spatial and contextual memory, is a particularly sensitive and vulnerable brain region to stress and stress hormones. The hippocampus shows a considerable degree of structural plasticity in the adult brain. Stress...

Cite
McEwen BS, Magarinos AM. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol. 2001;16:S7-S19doi: 10.1002/hup.266.
McEwen, B. S., & Magarinos, A. M. (2001). Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Human psychopharmacology, 16S7-S19. https://doi.org/10.1002/hup.266
McEwen, Bruce S., and Magarinos, Ana Maria. "Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders." Human psychopharmacology vol. 16 (2001): S7-S19. doi: https://doi.org/10.1002/hup.266
McEwen BS, Magarinos AM. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol. 2001 Jan;16:S7-S19. doi: 10.1002/hup.266. PMID: 12404531.
Copy Download .nbib Format: NLM
Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study.

Human psychopharmacology

Toren P, Eldar S, Laor N, Wolmer L, Samuel E, Weizman R.
PMID: 12404568
Hum Psychopharmacol. 2001 Jun;16(4):327-332. doi: 10.1002/hup.301.

Tricyclic antidepressants possess established antienuretic properties. The selective serotonin reuptake inhibitors (SSRIs) have similar antidepressant properties to the tricyclic antidepressants and a safer side effect profile. The aim of the present study was to evaluate the antienuretic efficacy of...

Cite
Toren P, Eldar S, Laor N, et al. Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study. Hum Psychopharmacol. 2001;16(4):327-332doi: 10.1002/hup.301.
Toren, P., Eldar, S., Laor, N., Wolmer, L., Samuel, E., & Weizman, R. (2001). Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study. Human psychopharmacology, 16(4), 327-332. https://doi.org/10.1002/hup.301
Toren, Paz, et al. "Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study." Human psychopharmacology vol. 16,4 (2001): 327-332. doi: https://doi.org/10.1002/hup.301
Toren P, Eldar S, Laor N, Wolmer L, Samuel E, Weizman R. Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study. Hum Psychopharmacol. 2001 Jun;16(4):327-332. doi: 10.1002/hup.301. PMID: 12404568.
Copy Download .nbib Format: NLM
Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression.

Human psychopharmacology

Halaris A, Piletz JE.
PMID: 12404600
Hum Psychopharmacol. 2001 Jan;16(1):65-69. doi: 10.1002/hup.185.

Imidazoline receptors (IR), a novel family of non-adrenergic receptors, are present in brain, especially the limbic system, and platelets among other organs. Their functions include central mediation of blood pressure control and possibly modulation of affective symptomatology. Studies of...

Cite
Halaris A, Piletz JE. Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression. Hum Psychopharmacol. 2001;16(1):65-69doi: 10.1002/hup.185.
Halaris, A., & Piletz, J. E. (2001). Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression. Human psychopharmacology, 16(1), 65-69. https://doi.org/10.1002/hup.185
Halaris, Angelos, and Piletz, John E. "Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression." Human psychopharmacology vol. 16,1 (2001): 65-69. doi: https://doi.org/10.1002/hup.185
Halaris A, Piletz JE. Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression. Hum Psychopharmacol. 2001 Jan;16(1):65-69. doi: 10.1002/hup.185. PMID: 12404600.
Copy Download .nbib Format: NLM
Novel approaches to the treatment of depression by modulating the hypothalamic - pituitary - adrenal axis.

Human psychopharmacology

Dinan T.
PMID: 12404603
Hum Psychopharmacol. 2001 Jan;16(1):89-93. doi: 10.1002/hup.188.

Many patients with major depression show evidence of over-activation of the hypothalamic - pituitary - adrenal axis (HPA), as evidenced by hypercortisolism and adrenal hyperplasia. Such over-activity is associated with increased corticotropin releasing factor (CRF) reactivity in the CSF...

Cite
Dinan T. Novel approaches to the treatment of depression by modulating the hypothalamic - pituitary - adrenal axis. Hum Psychopharmacol. 2001;16(1):89-93doi: 10.1002/hup.188.
Dinan, T. (2001). Novel approaches to the treatment of depression by modulating the hypothalamic - pituitary - adrenal axis. Human psychopharmacology, 16(1), 89-93. https://doi.org/10.1002/hup.188
Dinan, TimothyG. "Novel approaches to the treatment of depression by modulating the hypothalamic - pituitary - adrenal axis." Human psychopharmacology vol. 16,1 (2001): 89-93. doi: https://doi.org/10.1002/hup.188
Dinan T. Novel approaches to the treatment of depression by modulating the hypothalamic - pituitary - adrenal axis. Hum Psychopharmacol. 2001 Jan;16(1):89-93. doi: 10.1002/hup.188. PMID: 12404603.
Copy Download .nbib Format: NLM
Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance.

Human psychopharmacology

McAndrews MP, Kayumov L, Phillipson R, Shapiro CM.
PMID: 12404610
Hum Psychopharmacol. 2000 Dec;15(8):583-587. doi: 10.1002/hup.226.

Benzodiazepines produce memory disturbance after acute administration. It is not clear whether chronic use of benzodiazepines is hazardous to memory processes. Epidemiological data indicate that a large proportion (10-30 per cent) of individuals with sleep dysfunction take hypnotic aids...

Cite
McAndrews MP, Kayumov L, Phillipson R, et al. Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance. Hum Psychopharmacol. 2000;15(8):583-587doi: 10.1002/hup.226.
McAndrews, M. P., Kayumov, L., Phillipson, R., & Shapiro, C. M. (2000). Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance. Human psychopharmacology, 15(8), 583-587. https://doi.org/10.1002/hup.226
McAndrews, Mary Pat, et al. "Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance." Human psychopharmacology vol. 15,8 (2000): 583-587. doi: https://doi.org/10.1002/hup.226
McAndrews MP, Kayumov L, Phillipson R, Shapiro CM. Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance. Hum Psychopharmacol. 2000 Dec;15(8):583-587. doi: 10.1002/hup.226. PMID: 12404610.
Copy Download .nbib Format: NLM
Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia.

Human psychopharmacology

Drake CL, Roehrs TA, Mangano RM, Roth T.
PMID: 12404612
Hum Psychopharmacol. 2000 Dec;15(8):595-604. doi: 10.1002/hup.216.

The effects of two nights of treatment with the short-acting benzodiazepine receptor agonist zaleplon, triazolam, or placebo was assessed in chronic primary insomniacs using two concurrent, multi-center, randomized, double-blind, Latin Square crossover studies. Study 1 (n = 47) compared...

Cite
Drake CL, Roehrs TA, Mangano RM, et al. Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia. Hum Psychopharmacol. 2000;15(8):595-604doi: 10.1002/hup.216.
Drake, C. L., Roehrs, T. A., Mangano, R. M., & Roth, T. (2000). Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia. Human psychopharmacology, 15(8), 595-604. https://doi.org/10.1002/hup.216
Drake, Christopher L, et al. "Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia." Human psychopharmacology vol. 15,8 (2000): 595-604. doi: https://doi.org/10.1002/hup.216
Drake CL, Roehrs TA, Mangano RM, Roth T. Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia. Hum Psychopharmacol. 2000 Dec;15(8):595-604. doi: 10.1002/hup.216. PMID: 12404612.
Copy Download .nbib Format: NLM
Fenfluramine challenge in anxious children.

Human psychopharmacology

Sallee FR, Vrindavanam NS, Liu H, Sethuraman G, Sine L.
PMID: 12404615
Hum Psychopharmacol. 2000 Dec;15(8):619-629. doi: 10.1002/hup.219.

The study objective was to determine if serotonergic challenge with oral racemic fenfluramine would differentiate between childhood anxiety disorders in comparison to normal controls. Subjects were 24 children with anxiety diagnoses (DSM-IIIR) by structured interview, and 14 normal controls...

Cite
Sallee FR, Vrindavanam NS, Liu H, et al. Fenfluramine challenge in anxious children. Hum Psychopharmacol. 2000;15(8):619-629doi: 10.1002/hup.219.
Sallee, F. R., Vrindavanam, N. S., Liu, H., Sethuraman, G., & Sine, L. (2000). Fenfluramine challenge in anxious children. Human psychopharmacology, 15(8), 619-629. https://doi.org/10.1002/hup.219
Sallee, Floyd R, et al. "Fenfluramine challenge in anxious children." Human psychopharmacology vol. 15,8 (2000): 619-629. doi: https://doi.org/10.1002/hup.219
Sallee FR, Vrindavanam NS, Liu H, Sethuraman G, Sine L. Fenfluramine challenge in anxious children. Hum Psychopharmacol. 2000 Dec;15(8):619-629. doi: 10.1002/hup.219. PMID: 12404615.
Copy Download .nbib Format: NLM
Erratum: sedation and antihistamines.

Human psychopharmacology

[No authors listed]
PMID: 12404617
Hum Psychopharmacol. 2000 Dec;15(8):637-638. doi: 10.1002/hup.260.

No Abstract

Cite
Erratum: sedation and antihistamines. Hum Psychopharmacol. 2000;15(8):637-638doi: 10.1002/hup.260.
(2000). Erratum: sedation and antihistamines. Human psychopharmacology, 15(8), 637-638. https://doi.org/10.1002/hup.260
"Erratum: sedation and antihistamines." Human psychopharmacology vol. 15,8 (2000): 637-638. doi: https://doi.org/10.1002/hup.260
Erratum: sedation and antihistamines. Hum Psychopharmacol. 2000 Dec;15(8):637-638. doi: 10.1002/hup.260. PMID: 12404617.
Copy Download .nbib Format: NLM
Marijuana, alcohol and actual driving performance.

Human psychopharmacology

Ramaekers JG, Robbe HW, O'Hanlon JF.
PMID: 12404625
Hum Psychopharmacol. 2000 Oct;15(7):551-558. doi: 10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P.

The objective of the current study was to assess the separate and combined effects of marijuana and alcohol on actual driving performance. Eighteen subjects were treated with drugs and placebo according to a balanced, 6-way, crossover design. On separate...

Cite
Ramaekers JG, Robbe HW, O'Hanlon JF. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol. 2000;15(7):551-558doi: 10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P.
Ramaekers, J. G., Robbe, H. W., & O'Hanlon, J. F. (2000). Marijuana, alcohol and actual driving performance. Human psychopharmacology, 15(7), 551-558. https://doi.org/10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P
Ramaekers, J. G., et al. "Marijuana, alcohol and actual driving performance." Human psychopharmacology vol. 15,7 (2000): 551-558. doi: https://doi.org/10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P
Ramaekers JG, Robbe HW, O'Hanlon JF. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol. 2000 Oct;15(7):551-558. doi: 10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P. PMID: 12404625.
Copy Download .nbib Format: NLM
An introduction to enantiomers in psychopharmacology.

Human psychopharmacology

Leonard BE.
PMID: 12404712
Hum Psychopharmacol. 2001 Dec;16:S79-S84. doi: 10.1002/hup.335.

There is growing scientific, clinical, commercial and regulatory recognition that enantiomers offer benefits over racemates in the management of psychiatric diseases as well as in clinical medicine generally. However, relatively few studies consider enantiomers' individual characteristics. This review considers...

Cite
Leonard BE. An introduction to enantiomers in psychopharmacology. Hum Psychopharmacol. 2001;16:S79-S84doi: 10.1002/hup.335.
Leonard, B. E. (2001). An introduction to enantiomers in psychopharmacology. Human psychopharmacology, 16S79-S84. https://doi.org/10.1002/hup.335
Leonard, Brian E.. "An introduction to enantiomers in psychopharmacology." Human psychopharmacology vol. 16 (2001): S79-S84. doi: https://doi.org/10.1002/hup.335
Leonard BE. An introduction to enantiomers in psychopharmacology. Hum Psychopharmacol. 2001 Dec;16:S79-S84. doi: 10.1002/hup.335. PMID: 12404712.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 240 entries